Primary and Metastatic Liver Cancer

This is a joint virtual tumor board activity with the SSO and the Society of Interventional Oncology (SIO).

Melissa Hogg, MD, MS, NorthShore University Health System  
Yun Shin Chun, MD, MD Anderson Cancer Center
Charles Kim, MD, Duke University School of Medicine
Zach Berman, MD, UC San Diego Health
Mary Feng, MD, UCSF Health
Michael Morse, MD, Duke Cancer Center

• Discuss the roles of liver directed therapy and/or resection in patients with hepatocellular cancer.
• Discuss multimodality therapy options including resection and liver-directed therapies and strategies in the treatment of metastatic colorectal liver metastases.  
• Discuss the roles of resection versus liver-directed options in the treatment of intrahepatic cholangiocarcinoma.